Advertisement
Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limited (CLVLY) Stock Competitors & Peer Comparison

See (CLVLY) competitors and their performances in Stock Market.

CLVLYPNK
HealthcareBiotechnology
$6.19
$0.31(4.77%)
U.S. Market opens in NaNh NaNm
Advertisement

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CLVLY$6.36-5.47%320.6M14.13$0.45+0.52%
NONOF$41.70+1.09%183.6B9.70$4.26+4.33%
CSLLY$17.43+2.05%67.3B11.28$1.54+4.15%
UCBJY$151.74+1.05%57.8B32.50$4.67+0.56%
UCBJF$310.09+6.14%56B31.56$9.32+0.58%
ARGNF$885.00+5.99%54.8B39.26$22.54N/A
CMXHF$67.55-4.40%32.4B10.95$6.17+4.32%
WXIBF$4.40+0.00%18.2B25.88$0.17N/A
IVBXF$9.10+0.00%15.8B130.00$0.07N/A
WXXWY$7.60-2.31%15.7B22.34$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CLVLY vs NONOF Comparison June 2026

CLVLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CLVLY stands at 320.6M. In comparison, NONOF has a market cap of 183.6B. Regarding current trading prices, CLVLY is priced at $6.36, while NONOF trades at $41.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CLVLY currently has a P/E ratio of 14.13, whereas NONOF's P/E ratio is 9.70. In terms of profitability, CLVLY's ROE is +0.13%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, CLVLY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for CLVLY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions